Livagen 20 mg vial
- Biolongevity Labs$79.97Listed price · deal not verifiedCOA tested Jan 16, 2026
Livagen is a short-peptide product commonly placed in the bioregulator category.
Also known as livagen
Current picks · Nov 14, 2026
Up to three of the lowest effective prices per exact product among vendors that passed the trust floor, were in stock and checked within 72 hours, and have a COA on file for that product and strength tested within 12 months. Affiliate relationships never affect picks or their order.
Same format. Same amount.
1 of 1 exact products have at least one pick. Vendor counts reflect the current price observations. Testing records for every vendor and strength: Livagen COAs →
Historical market context
Historical market low and median per mg across recorded offers. These market summaries are separate from our exact-product comparisons.
History updated Sep 21, 2026. Vendor coverage, package sizes, product forms and promotions can vary over time. Use exact-product comparisons for current listed prices; historical market prices do not establish vendor trust.
| Date | Low /mg | Median /mg | Vendors | Offers |
|---|---|---|---|---|
| $1.89 | $2.65 | 6 | 9 | |
| $1.89 | $2.65 | 6 | 9 | |
| $1.89 | $2.45 | 5 | 8 | |
| $1.89 | $2.17 | 3 | 6 |
What it is
PubChem identifies the record as Livagen. The listed molecular formula is C18H31N5O9. PepGrades separately preserves the catalog category because a chemical identity record does not establish a use, outcome, or product quality.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
No registered human trial was identified under this exact name in the current review. Published work may be preclinical or indexed under another name.
Search indexed research for this compound ↗Market context
Livagen is commonly sold or discussed for organ-specific bioregulator research and general wellness goals. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Vendor directory
Grades describe the vendor record overall, not a test of every product. Lowest prices are effective single-package prices across formats; open a comparison for the exact product.
| Vendor | Grade | Offers | In stock | Lowest effective package |
|---|---|---|---|---|
| Core Peptides | Grade B+ | 1 | 1 | $73 · 20 mg vialEarlier observation Oct 20, 2026 |
| Biolongevity Labs | Grade B | 1 | 1 | $79.97 · 20 mg vialObserved Nov 14, 2026 |
| Coffee and Peppers | Grade B | 1 | 0 | $59.99 · 20 mg vialEarlier observation Oct 4, 2026 · out of stock |
| Swiss Chems | Grade C | 1 | 1 | $62.95 · 20 mg vialObserved Nov 14, 2026 |
| Nuscience Peptides | Not graded | 1 | 1 | $59.99 · 20 mg vialObserved Nov 14, 2026 |
| Skye Peptides | Not graded | 1 | 1 | $69 · 20 mg vialObserved Nov 14, 2026 |
1 tracked vendor lists Livagen without a current offer: Peptidology (Grade C).
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.